BRNS - Company ID 0001828185
The table below shows Barinthus Biotherapeutics plc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $70.46M | $110.66M | $142.09M | $194.38M | $214.05M |
| Short-term investments | - | - | - | - | - |
| Receivables | - | - | - | $323.00K | $20.00K |
| Inventory | - | - | - | - | - |
| Total current assets | $77.79M | $125.74M | $156.91M | $213.04M | $226.76M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $3.52M | $7.37M | $11.82M | $7.96M | $1.83M |
| Goodwill | - | $0.00 | $12.21M | $12.21M | $12.63M |
| Total assets | $98.17M | $160.33M | $214.51M | $270.20M | $280.71M |
| Accounts payable | $350.00K | $2.47M | $1.60M | $3.75M | $2.42M |
| Total current liabilities | $10.02M | $15.66M | $12.60M | $12.24M | $11.16M |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $23.88M | $30.19M | $27.51M | $27.00M | $28.15M |
| Retained earnings | -$304.09M | -$237.66M | -$176.59M | -$103.24M | -$108.58M |
| Total equity | $74.21M | $130.03M | $186.78M | $242.90M | - |